Sequential treatment failures in response to BRAF/MEK and immune checkpoint inhibitors mediated by MAP2K2 and B2M mutations in melanoma
Richmond, Craig S., Vallatharasu, Yazhini, Deviley, Jake A., Vos, Cullen R., Parsons, Benjamin M., Kenny, Paraic A.
Published in Experimental and molecular pathology (01.10.2019)
Published in Experimental and molecular pathology (01.10.2019)
Get full text
Journal Article